MarketCapExport financials
Oracle (ORCL)
The export includes the complete available history of financial statements and ratios. Numbers are provided in full, without million or billion abbreviations, in their original reporting units.
CSV downloads as a ZIP archive with one file for each report and frequency.
Facebook
X
Telegram
Oracle Financial Ratios 2026-2007 | ORCL
Brief overview of Oracle's multiples and efficiency
Current figures are compared with the company's own five-year history for 2022–2026.
The valuation comparison uses P/E 29.3x (median 47.26x), EV/EBITDA 16.63x (median 23.99x), P/S 7.43x (median 7.79x). On average, this basket is 36.8% below its own five-year medians. The market values the business at a discount to recent history.
At the current P/E, inverse earnings yield is 3.4%, a useful bridge between price and business earnings.
Capital efficiency is characterized by ROE 40.2%, ROA 6.5%, ROCE 9.4%. Quality ratios send a mostly positive signal: resources are productive, with room for improvement.
Price, earnings and growth produce a PEG of 2.29x. A high value reduces the cushion if growth slows.
Cash turnover speed was broadly preserved, with the cycle moving from 48.9 days to 51.3 days.
Overall picture
Oracle's high-quality returns come with historically restrained multiples. Price appears more cautious than current business efficiency.
Annual Financial Ratios Oracle
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
29.3 | 47.3 | 55.3 | 38.8 | 49.2 | 16.2 | 17.5 | 18.7 | 47.5 | 22.1 | 19.4 | 17.9 | 16.8 | 13.4 | 14.9 | 19.4 | 18.1 | 17.8 | 20.9 | - |
P/S |
7.4 | 10.2 | 10.9 | 6.6 | 7.8 | 5.5 | 4.5 | 5.2 | 4.6 | 5.5 | 4.7 | 4.6 | 4.8 | 3.9 | 4.0 | 4.7 | 4.2 | 4.3 | 5.2 | - |
EPS |
5.9 | 4.5 | 3.8 | 3.1 | 2.5 | 4.7 | 3.2 | 3.0 | 0.9 | 2.3 | 2.1 | 2.3 | 2.4 | 2.3 | 2.0 | 1.7 | 1.2 | 1.1 | 1.1 | - |
EV (Enterprise Value) |
469 B | 577 B | 568 B | 321 B | 309 B | 193 B | 243 B | 273 B | 251 B | 265 B | 217 B | 218 B | 209 B | 169 B | 168 B | 183 B | 101 B | 92 B | 108 B | -6.22 B |
EBITDA per Share |
9.87 | 7.72 | 6.74 | 5.79 | 4.78 | 5.69 | 4.92 | 4.32 | 3.87 | 3.58 | 3.49 | 3.73 | 3.82 | 3.53 | 3.29 | 3 | 1.87 | 1.69 | 1.58 | - |
EV/EBITDA |
16.6 | 26.8 | 30.7 | 20.5 | 24.0 | 11.4 | 13.4 | 15.4 | 13.8 | 16.5 | 13.3 | 12.0 | 11.0 | 8.9 | 9.1 | 10.9 | 10.8 | 10.7 | 13.3 | - |
PEG |
2.29 | 4.56 | 5.42 | 4.19 | 7.39 | 1.57 | 4.86 | 0.08 | -0.8 | 2.91 | -2.92 | -2.7 | 2.95 | 0.89 | 0.84 | 0.5 | - | - | - | - |
P/B |
1.9 | 3.5 | 4.1 | 2.5 | 3.0 | 1.7 | 14.7 | 9.5 | 4.0 | 3.8 | 3.7 | 3.6 | 3.9 | 3.3 | 3.4 | 4.2 | 1.8 | 2.1 | - | - |
P/CF |
15.7 | 28.2 | 31.0 | 19.2 | 34.7 | 14.0 | 15.3 | 16.1 | 13.3 | 17.0 | 14.0 | 13.7 | 12.8 | 10.8 | 11.4 | 15.4 | 12.8 | 12.2 | 15.7 | - |
ROE % |
40.20 | 60.84 | 113.29 | 792.45 | -107.99 | 230.95 | 83.94 | 50.87 | 8.37 | 17.33 | 18.82 | 20.42 | 23.37 | 24.47 | 22.85 | 21.49 | 19.92 | 22.63 | 23.86 | - |
ROA % |
6.53 | 7.39 | 7.42 | 6.33 | 6.15 | 10.48 | 8.78 | 10.20 | 2.79 | 6.92 | 7.93 | 8.96 | 12.13 | 13.35 | 12.74 | 11.62 | 9.96 | 11.97 | - | - |
ROCE % |
9.39 | 13.08 | 14.03 | 11.82 | 12.23 | 14.23 | 14.46 | 15.57 | 12.13 | 11.98 | 13.80 | 14.94 | 19.73 | 20.93 | 22.33 | 21.45 | 19.49 | 21.95 | 33.53 | - |
Current Ratio |
- | - | - | - | - | - | 3.0 | 2.5 | 4.0 | 3.1 | 3.7 | 4.1 | 3.3 | 3.2 | 2.6 | 2.8 | - | - | - | - |
DSO |
51.3 | 52.2 | 51.0 | 47.0 | 48.9 | 49.4 | 51.9 | 47.4 | 48.4 | 51.3 | 53.1 | 53.6 | 58.0 | 59.4 | 62.7 | 67.9 | 68.1 | 34.8 | - | - |
DIO |
- | - | - | - | - | - | - | - | - | 14.7 | 10.3 | 15.2 | 9.5 | 12.3 | 7.3 | 13.2 | 53.7 | - | - | - |
DPO |
- | - | - | - | - | - | 29.3 | 26.5 | 23.9 | 29.3 | 24.6 | 39.1 | 23.8 | 21.5 | 20.3 | 30.5 | 216.9 | - | - | - |
Operating Cycle |
51.3 | 52.2 | 51.0 | 47.0 | 48.9 | 49.4 | 51.9 | 47.4 | 48.4 | 65.9 | 63.4 | 68.9 | 67.6 | 71.7 | 70.0 | 81.1 | 121.9 | 34.8 | - | - |
Cash Conversion Cycle |
51.3 | 52.2 | 51.0 | 47.0 | 48.9 | 49.4 | 22.6 | 21.0 | 24.5 | 36.7 | 38.8 | 29.8 | 43.8 | 50.2 | 49.7 | 50.6 | -95.1 | 34.8 | - | - |
All numbers in USD currency
Quarterly Financial Ratios Oracle
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
1.29 | 2.14 | 1.29 | 1.04 | - | 1.05 | 1.13 | 1.06 | - | 0.87 | 0.91 | 0.89 | - | 0.7 | 0.65 | 0.58 | 1.22 | 0.87 | -0.46 | 0.89 | 0.44 | 1.72 | 0.82 | 0.74 | 0.82 | 0.74 | 0.71 | 0.64 | 0.71 | 0.64 | 0.63 | 0.58 | 0.63 | 0.58 | 0.53 | 0.52 | 0.54 | 0.53 | 0.5 | 0.44 | 0.5 | 0.44 | 0.52 | 0.4 | 0.52 | 0.4 | 0.57 | 0.49 | 0.57 | 0.49 | 0.56 | 0.48 | 0.56 | 0.48 | 0.54 | 0.42 | 0.54 | 0.42 | 0.43 | 0.36 | 0.43 | 0.36 | 0.24 | 0.29 | 0.22 |
EBITDA per Share |
3.71 | 2.72 | 2.04 | 1.99 | - | 1.75 | 1.72 | 1.74 | - | 1.64 | 1.59 | 1.47 | - | 1.54 | 1.48 | 1.18 | 2.54 | 1.54 | -0.19 | 1.4 | 1.29 | 1.45 | 1.32 | 1.17 | 1.45 | 1.17 | 1.11 | 0.97 | 1.19 | 0.97 | 0.95 | 0.78 | 0.99 | 0.78 | 0.83 | 0.73 | 0.88 | 0.75 | 0.81 | 0.7 | 0.85 | 0.7 | 0.8 | 0.67 | 0.8 | 0.67 | 0.93 | 0.7 | 0.88 | 0.7 | 0.88 | 0.66 | 0.82 | 0.66 | 0.85 | 0.62 | 0.78 | 0.62 | 0.73 | 0.55 | 0.66 | 0.55 | 0.41 | 0.46 | 0.36 |
ROE % |
51.93 | 59.28 | 61.72 | 78.04 | 65.92 | 108.62 | 148.79 | 211.04 | 185.05 | 85.89 | -2.92 | -88.50 | -173.68 | -226.56 | -154.06 | -95.04 | -284.07 | -208.11 | -85.58 | -67.65 | 173.50 | 170.64 | 93.43 | 77.44 | 65.31 | 55.69 | 46.86 | 39.64 | 34.00 | 28.42 | 23.50 | 19.83 | 17.71 | 16.82 | 16.04 | 16.27 | 16.30 | 16.46 | 16.23 | 16.82 | 16.66 | 16.88 | 16.60 | 17.08 | 17.98 | 18.80 | 19.87 | 20.47 | 20.89 | 21.27 | 21.52 | 21.66 | 21.32 | 21.51 | 21.26 | 20.49 | 20.29 | 24.52 | 25.19 | 24.13 | 24.93 | 19.09 | 4.18 | 5.30 | 4.30 |
ROA % |
7.65 | 8.25 | 7.29 | 7.53 | 5.90 | 5.90 | 7.77 | 7.42 | 5.39 | 6.74 | 6.18 | 7.32 | 5.55 | 5.55 | 7.69 | 5.17 | 5.98 | 3.89 | 5.58 | 8.97 | 8.95 | 10.15 | 8.27 | 8.40 | 8.42 | 8.44 | 8.45 | 8.08 | 7.83 | 7.39 | 7.07 | 6.70 | 6.54 | 6.50 | 6.49 | 6.54 | 6.42 | 6.58 | 6.58 | 6.99 | 7.10 | 7.27 | 7.21 | 7.69 | 8.29 | 9.08 | 9.92 | 10.37 | 10.72 | 11.07 | 11.33 | 11.57 | 11.70 | 11.87 | 11.79 | 11.56 | 11.39 | 13.58 | 13.86 | 12.85 | 13.07 | 9.71 | 2.00 | 2.71 | 2.12 |
ROCE % |
11.25 | 33.82 | 34.53 | 35.41 | 32.35 | 35.71 | 13.76 | 13.17 | 9.62 | -160.89 | -161.22 | -161.76 | -164.73 | -158.35 | 16.53 | 12.56 | 13.25 | 9.32 | 8.60 | 13.61 | 13.58 | 14.81 | 14.45 | 14.20 | 14.10 | 13.99 | 13.91 | 13.27 | 12.52 | 11.58 | 10.72 | 10.01 | 9.88 | 10.04 | 10.24 | 10.61 | 10.63 | 11.06 | 11.30 | 11.66 | 12.04 | 11.93 | 11.92 | 12.84 | 13.47 | 15.07 | 16.21 | 16.85 | 17.42 | 17.70 | 17.96 | 18.39 | 19.00 | 19.57 | 19.97 | 19.84 | 19.65 | 19.38 | 19.34 | 18.40 | 18.81 | 17.52 | 4.12 | 4.85 | 4.00 |
DSO |
53.5 | 57.3 | 51.9 | 53.2 | - | 26.4 | 52.6 | 54.5 | - | 48.5 | 47.0 | 49.2 | - | 22.8 | 45.1 | 47.4 | 180.5 | 39.3 | 39.4 | 46.4 | 24.6 | 44.5 | 41.9 | 49.3 | 13.0 | 46.8 | 37.4 | 44.3 | 11.9 | 45.1 | 36.8 | 44.0 | 11.9 | 41.7 | 35.0 | 44.1 | 25.7 | 44.6 | 35.8 | 46.7 | 54.4 | 49.6 | 37.7 | 49.1 | 57.0 | 53.7 | 37.4 | 51.2 | 57.9 | 54.6 | 37.6 | 51.8 | 59.5 | 57.0 | 41.0 | 56.6 | 64.0 | 60.3 | 44.8 | 59.0 | 68.8 | 288.6 | 49.8 | 44.2 | - |
DIO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 60.6 | 69.8 | - | - |
DPO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 129.2 | 192.9 | - | - |
Operating Cycle |
- | - | 51.9 | 53.2 | - | - | 52.6 | 54.5 | - | 48.5 | 47.0 | 49.2 | - | 22.8 | 45.1 | 47.4 | 180.5 | 39.3 | 39.4 | 46.4 | 24.6 | 44.5 | 41.9 | 49.3 | 13.0 | 46.8 | 37.4 | 44.3 | 11.9 | 45.1 | 36.8 | 44.0 | 11.9 | 41.7 | 35.0 | 44.1 | 25.7 | 44.6 | 35.8 | 46.7 | 54.4 | 49.6 | 37.7 | 49.1 | 57.0 | 53.7 | 37.4 | 51.2 | 57.9 | 54.6 | 37.6 | 51.8 | 59.5 | 57.0 | 41.0 | 56.6 | 64.0 | 60.3 | 44.8 | 59.0 | 68.8 | - | - | - | - |
Cash Conversion Cycle |
- | - | 51.9 | 53.2 | - | - | 52.6 | 54.5 | - | 48.5 | 47.0 | 49.2 | - | 22.8 | 45.1 | 47.4 | 180.5 | 39.3 | 39.4 | 46.4 | 24.6 | 44.5 | 41.9 | 49.3 | 13.0 | 46.8 | 37.4 | 44.3 | 11.9 | 45.1 | 36.8 | 44.0 | 11.9 | 41.7 | 35.0 | 44.1 | 25.7 | 44.6 | 35.8 | 46.7 | 54.4 | 49.6 | 37.7 | 49.1 | 57.0 | 53.7 | 37.4 | 51.2 | 57.9 | 54.6 | 37.6 | 51.8 | 59.5 | 57.0 | 41.0 | 56.6 | 64.0 | 60.3 | 44.8 | 59.0 | 68.8 | - | - | - | - |
All numbers in USD currency
Multiples are an important financial analysis tool for the company Oracle, allowing investors and analysts to quickly assess the company’s value and investment attractiveness based on the ratio of market indicators to the company’s financial performance. Essentially, multiples express how the market values the company relative to its earnings, revenue, equity, or other key metrics.
Advantages of Using Financial Ratios- Simplified Data Analysis
Financial ratios transform large volumes of accounting data into compact and easily interpretable indicators, significantly simplifying the assessment of the company’s condition. - Comparability Between Companies
Multiples standardize financial metrics, enabling objective comparison of companies of different sizes, industries, and market capitalizations. - Identification of Trends and Issues
Regular analysis of ratios helps track the dynamics of financial health, identify strengths and weaknesses of the business, as well as potential risks. - Decision Support
Financial multiples serve as an important tool for investors, creditors, and company management in making investment, credit, and managerial decisions. - Accelerated Assessment of Investment Attractiveness
Ratios allow quick determination of key performance, liquidity, and financial stability indicators, facilitating prompt evaluation of companies’ attractiveness for investments.
Using multiples enables comparison between companies, even if they differ in size or industry, as they standardize financial data into ratios convenient for analysis. This is especially useful for evaluating companies where direct analysis of financial statements may be complex or require in-depth knowledge.
Russia
USA
Britain
China
Israel
South-africa
Curacao
